Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 11/2018

27.07.2018 | Multimedia Article

Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique

verfasst von: Naruhiko Ikoma, Jeannelyn S. Estrella, Wayne L. Hofstetter, Jaffer A. Ajani, Keith F. Fournier, Paul F. Mansfield, John M. Skibber, Brian D. Badgwell

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In the majority of US institutions, gastrectomy specimens are sent for pathologic examination without surgeon assessment or standardized technique of lymph node (LN) assessment for gastric cancer. We conducted a quality improvement project at a US cancer center utilizing surgeon assessment of gastric LNs, and created a video to illustrate a technique of standardized lymph node assessment.

Methods

Convenience sampling was employed among patients with gastric adenocarcinomas who underwent curative-intent D2 gastrectomy between July 2016 and June 2017. For each patient, a surgeon assessed gastric LNs by harvesting individual LNs, followed by conventional evaluation by a pathologist.

Results

We enrolled 17 patients for this quality improvement project. Eight patients underwent total gastrectomy, and nine patients underwent subtotal gastrectomy. Twelve patients underwent preoperative chemoradiation therapy, three underwent preoperative chemotherapy alone, and two underwent upfront surgery. The median number of examined LNs was 43. All patients had ≥ 16 LNs examined, and 88% of patients had ≥ 30 LNs examined.

Conclusion

Surgeon assessment of gastric LN specimens was feasible and effective to provide high-quality pathologic LN assessment after gastrectomy in gastric adenocarcinoma patients. Standardization of the technical methods for gastric LN evaluation is needed to improve the accuracy and quality of gastric cancer staging in the US. The provided video can help inform standardization of gastric LN assessment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Badgwell B. Multimodality Therapy of Localized Gastric Adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1321–1327.CrossRef Badgwell B. Multimodality Therapy of Localized Gastric Adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1321–1327.CrossRef
2.
Zurück zum Zitat Ikoma N, Blum M, Chiang YJ, et al. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer. Annals of surgical oncology. 2017;24(4):960–965.CrossRef Ikoma N, Blum M, Chiang YJ, et al. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer. Annals of surgical oncology. 2017;24(4):960–965.CrossRef
3.
Zurück zum Zitat Ikoma N, Blum M, Chiang YJ, et al. Survival rates in T1 and T2 gastric cancer: A Western report. Journal of surgical oncology. 2016;114(5):602–606.CrossRef Ikoma N, Blum M, Chiang YJ, et al. Survival rates in T1 and T2 gastric cancer: A Western report. Journal of surgical oncology. 2016;114(5):602–606.CrossRef
4.
Zurück zum Zitat Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89(11):2237–2246.CrossRef Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89(11):2237–2246.CrossRef
5.
Zurück zum Zitat Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. AJCC Manual for staging of cancer. 5th ed. Philadelphia: Lippincott-Raven, 1997. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. AJCC Manual for staging of cancer. 5th ed. Philadelphia: Lippincott-Raven, 1997.
6.
Zurück zum Zitat Ikoma N, Estrella JS, Blum M, et al. Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018. Ikoma N, Estrella JS, Blum M, et al. Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018.
7.
Zurück zum Zitat Ikoma N, Blum M, Estrella JS, et al. Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017;21(10):1563–1570.CrossRef Ikoma N, Blum M, Estrella JS, et al. Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017;21(10):1563–1570.CrossRef
8.
Zurück zum Zitat Chen J, Chen C, He Y, Wu K, Wu H, Cai S. A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2014;18(12):2080–2088.CrossRef Chen J, Chen C, He Y, Wu K, Wu H, Cai S. A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2014;18(12):2080–2088.CrossRef
9.
Zurück zum Zitat Zhao B, Zhang J, Zhang J, et al. Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection. Scandinavian journal of gastroenterology. 2018;53(2):185–192.CrossRef Zhao B, Zhang J, Zhang J, et al. Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection. Scandinavian journal of gastroenterology. 2018;53(2):185–192.CrossRef
10.
Zurück zum Zitat Anderegg MC, Lagarde SM, Jagadesham VP, et al. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction. Annals of surgery. 2016;264(5):847–853.CrossRef Anderegg MC, Lagarde SM, Jagadesham VP, et al. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction. Annals of surgery. 2016;264(5):847–853.CrossRef
11.
Zurück zum Zitat Ajani JA, D'Amico TA, Almhanna K, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1286–1312.CrossRef Ajani JA, D'Amico TA, Almhanna K, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1286–1312.CrossRef
12.
Zurück zum Zitat Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual 8th edition. New York: Springer; 2017.CrossRef Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual 8th edition. New York: Springer; 2017.CrossRef
13.
Zurück zum Zitat Morgan JW, Ji L, Friedman G, Senthil M, Dyke C, Lum SS. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA surgery. 2015;150(1):37–43.CrossRef Morgan JW, Ji L, Friedman G, Senthil M, Dyke C, Lum SS. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA surgery. 2015;150(1):37–43.CrossRef
14.
Zurück zum Zitat Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017;20(1):1–19.CrossRef Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017;20(1):1–19.CrossRef
15.
Zurück zum Zitat Badgwell B, Ajani J, Blum M, et al. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy. Annals of surgical oncology. 2016;23(1):156–162.CrossRef Badgwell B, Ajani J, Blum M, et al. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy. Annals of surgical oncology. 2016;23(1):156–162.CrossRef
16.
Zurück zum Zitat Badgwell B, Blum M, Estrella J, et al. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy. Journal of the American College of Surgeons. 2015;221(1):83–90.CrossRef Badgwell B, Blum M, Estrella J, et al. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy. Journal of the American College of Surgeons. 2015;221(1):83–90.CrossRef
17.
Zurück zum Zitat Badgwell B, Blum M, Elimova E, et al. Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma. Annals of surgical oncology. 2016;23(6):1948–1955.CrossRef Badgwell B, Blum M, Elimova E, et al. Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma. Annals of surgical oncology. 2016;23(6):1948–1955.CrossRef
18.
Zurück zum Zitat Schoenleber SJ, Schnelldorfer T, Wood CM, Qin R, Sarr MG, Donohue JH. Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg. 2009;13(7):1233–1237.CrossRef Schoenleber SJ, Schnelldorfer T, Wood CM, Qin R, Sarr MG, Donohue JH. Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg. 2009;13(7):1233–1237.CrossRef
19.
Zurück zum Zitat Cichowitz A, Burton P, Brown W, et al. Ex vivo dissection increases lymph node yield in oesophagogastric cancer. ANZ journal of surgery. 2015;85(1–2):80–84.CrossRef Cichowitz A, Burton P, Brown W, et al. Ex vivo dissection increases lymph node yield in oesophagogastric cancer. ANZ journal of surgery. 2015;85(1–2):80–84.CrossRef
20.
Zurück zum Zitat Hanna GB, Amygdalos I, Ni M, et al. Improving the standard of lymph node retrieval after gastric cancer surgery. Histopathology. 2013;63(3):316–324.CrossRef Hanna GB, Amygdalos I, Ni M, et al. Improving the standard of lymph node retrieval after gastric cancer surgery. Histopathology. 2013;63(3):316–324.CrossRef
21.
Zurück zum Zitat Lavy R, Hershkovitz Y, Kapiev A, et al. A comparative study on two different pathological methods to retrieve lymph nodes following gastrectomy. Int J Surg. 2014;12(7):725–728.CrossRef Lavy R, Hershkovitz Y, Kapiev A, et al. A comparative study on two different pathological methods to retrieve lymph nodes following gastrectomy. Int J Surg. 2014;12(7):725–728.CrossRef
22.
Zurück zum Zitat Afaneh C, Levy A, Selby L, et al. Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2016;20(1):165–171; discussion 171.CrossRef Afaneh C, Levy A, Selby L, et al. Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2016;20(1):165–171; discussion 171.CrossRef
23.
Zurück zum Zitat Ha YH, Jeong SY, Lim SB, et al. Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Annals of surgery. 2010;252(2):336–340.CrossRef Ha YH, Jeong SY, Lim SB, et al. Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Annals of surgery. 2010;252(2):336–340.CrossRef
24.
Zurück zum Zitat Damin DC, Rosito MA, Contu PC, et al. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2012;16(8):1573–1580.CrossRef Damin DC, Rosito MA, Contu PC, et al. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2012;16(8):1573–1580.CrossRef
25.
Zurück zum Zitat Kim HJ, Jo JS, Lee SY, Kim CH, Kim YJ, Kim HR. Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response. Annals of surgical oncology. 2015;22(6):2075–2081.CrossRef Kim HJ, Jo JS, Lee SY, Kim CH, Kim YJ, Kim HR. Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response. Annals of surgical oncology. 2015;22(6):2075–2081.CrossRef
26.
Zurück zum Zitat Dikken JL, van Grieken NC, Krijnen P, et al. Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2012;38(4):319–325.CrossRef Dikken JL, van Grieken NC, Krijnen P, et al. Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2012;38(4):319–325.CrossRef
Metadaten
Titel
Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique
verfasst von
Naruhiko Ikoma
Jeannelyn S. Estrella
Wayne L. Hofstetter
Jaffer A. Ajani
Keith F. Fournier
Paul F. Mansfield
John M. Skibber
Brian D. Badgwell
Publikationsdatum
27.07.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 11/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3880-0

Weitere Artikel der Ausgabe 11/2018

Journal of Gastrointestinal Surgery 11/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.